Search Results - "Chew, Sonya"

New strategies for the treatment of breast cancer with leptomeningeal metastasis by Chew, Sonya M., Seidman, Andrew D.

“…PURPOSE OF REVIEWLeptomeningeal metastasis is a complication of metastatic breast cancer that has a rising incidence likely due to the increased availability…”
Get full text

Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes by Chew, Sonya M., Ferraro, Emanuela, Safonov, Anton, Chen, Yuan, Kelly, Daniel, Razavi, Pedram, Robson, Mark, Seidman, Andrew D.

“…Cyclin dependent kinase 4/6 inhibitors (CDK4/6i) are recommended 1st line treatments in HR+HER2- metastatic breast cancer. However, the impact of prior CDK4/6i…”
Get full text

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer by Slattery, Karen, Woods, Elena, Zaiatz-Bittencourt, Vanessa, Marks, Sam, Chew, Sonya, Conroy, Michael, Goggin, Caitriona, MacEochagain, Colm, Kennedy, John, Lucas, Sophie, Finlay, David K, Gardiner, Clair M

“…BackgroundNatural killer (NK) cells provide important immune protection from cancer and are a key requirement for particular immunotherapies. There is…”
Get full text

The Role of Obesity and Inflammation in Breast Cancer Recurrence by Chew, Sonya M., Liu, Bethina, Shen, Sherry, Iyengar, Neil M.

“…Purpose of review The purpose of this study is to summarize the latest findings regarding the impact of obesity and inflammation on breast cancer recurrence…”
Get full text

Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab by Chew, Sonya, Ferraro, Emanuela, Chen, Yuan, Barrio, Andrea Veronica, Kelly, Daniel W., Modi, Shanu, Seidman, Andrew David, Wen, Hannah Yong, Brogi, Edi, Robson, Mark E., Dang, Chau T.

“…589 Background: Patients (pts) with human epidermal growth factor receptor 2 (HER2) positive (+) early breast cancer (EBC) receiving neoadjuvant systemic…”
Get full text

Characterization of treatments and disease course for women with breast cancer brain metastases: Five-year retrospective single institution experience by Chew, Sonya, Carroll, Hailey Kathryn, Darwish, Waseem Mohammed Zaid, Higgins, Michaela Jane, McCaffrey, John, Kelly, Catherine Margaret

“…Abstract only e13055 Background: Up to 30% of patients (pts) with breast cancer (BC) will develop brain metastases (BM) during the course of their disease. BM…”
Get full text

SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy by Chew, Sonya Minmin, Lucas, Mairi, Brady, Michelle, Kelly, Catherine Margaret

“…A woman in her 40s presented to the emergency department with headache and unintentional weight loss in September 2018. Investigations revealed a widely…”
Get full text

Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy by O'Reilly, David, Farooq, Abdul Rehman, Nevins Selvadurai, Paul, Sheehan, Laura, Molan, Karen, Krishnanivas, Bindu, Mullen, Valerie, McMahon, David, Hadi, Danial, Ahmed, Ahmed, Jennings, Maeve, Carroll, Hailey, Chew, Sonya, Macanovic, Bojan, O'Hanlon Brown, Ciara, Noonan, Sinéad A, O Reilly, Seamus, Connolly, Roisin M, Cahir, Caitriona, Kelly, Catherine M

“…Early discontinuation of endocrine therapy (ET) is higher among patients with early breast cancer (EBC) compared to patients with metastatic hormone…”
Get full text

Abstract P4-01-09: Characterization of breast cancer brain metastases overall and progression-free survival and timing of cyclin-dependent kinase 4/6 inhibitor use: Retrospective single institution experience by Minmin, Sonya Chew, Chen, Yuan, Kelly, Daniel, Robson, Mark E., Seidman, Andrew D

“…Background Approximately 15% of patients (pts) with hormone receptor (HR)+ human epidermal growth factor receptor 2 (HER2)- breast cancer will develop brain…”
Get full text

Virtual oncology clinics during the COVID-19 pandemic by O’Reilly, David, Carroll, Hailey, Lucas, Mairi, Sui, Jane, Al Sendi, Maha, McMahon, David, Darwish, Waseem, McLaughlin, Ronan, Khan, Mohammed Raza, Sullivan, Hazel O, Chew, Sonya, Dennehy, Colum, Kelly, Catherine M., McCaffrey, John, Greally, Megan, Carney, Desmond, Higgins, Michaela J.

“…Background The COVID-19 pandemic has resulted in radical changes in the delivery of healthcare worldwide. Our oncology service (at an Irish national cancer…”
Get full text

Abstract P4-02-14: Gain of HER2 Amplification in Patients with HR+/HER2- and Triple Negative Early Breast Cancer Treated with Neoadjuvant Chemotherapy by Ferraro, Emanuela, Minmin, Sonya Chew, Safonov, Anton, Barrio, Andrea V., Modi, Shanu, Seidman, Andrew D, Wen, Hanna Y, Brogi, Edi, Robson, Mark E., Dang, Chau T

“…Background: Neoadjuvant chemotherapy (NAC) is standard of care for the majority of patients with clinical stage II-III triple negative breast cancer (TNBC) and…”
Get full text

Characterization of Treatments and Disease Course for Women with Breast Cancer Brain Metastases: 5-Year Retrospective Single Institution Experience by Chew, Sonya, Carroll, Hailey Kathryn, Darwish, Waseem, Boychak, Oleksandr, Higgins, Michaela, McCaffrey, John, Kelly, Catherine Margaret

“…Around 30% of patients with breast cancer will develop brain metastases (BM). We sought to characterize the disease course, treatments and outcome for our…”
Get full text

Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature by Watson, Geoffrey A, Ahmed, Yasar, Picardo, Sarah, Chew, Sonya, Cobbe, Shona, Mahony, Cillian, Crotty, James, Wallis, Fintan, Shelly, Martin J, Kiely, Patrick, Ipadeola, Olu Bunmi, Healy, Vourneen, Osman, Nemer, Gupta, Rajnish K

“…BACKGROUND Neuroendocrine tumors (NETs) encompass a diverse group of varying clinicopathological entities arising from cells of the endocrine and nervous…”
Get full text